ERBB2 and neoplasm: In terms of pathological markers, the tumor mass was estrogen receptor (ER) negative, progesterone receptor (PR) positive, and human epidermal growth factor receptor 2 (HER2) positive, with low expression of P53 (Fig. 1c).